| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Opus Genetics, Inc. (IRD) has 10 insiders with recent SEC Form 4 filings, including 11 buys and 0 sells. IRD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 5.49M | $27.41M | - | |
| ? | 1.99M | $9.94M | - | |
| CEO | 1.29M | $6.45M | - | |
| Pres | 319.0K | $1.59M | - | |
| ? | 297.3K | $1.48M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 20, 2022 | Manuso James S J | Director | Buy | 5,000 | $1.99 | $9,950.00 | +30.2% | +34.3% | +115.9% | |
| May 20, 2022 | Sooch Mina | President And CEO | Buy | 25,000 | $2.05 | $51,178.75 | +3.1% | +34.3% | +115.9% | |
| Dec 13, 2021 | Pepose Jay | Director | Buy | 8,250 | $3.65 | $30,112.50 | +56.0% | -14.2% | -17.4% | |
| Nov 18, 2021 | Manuso James S J | Director | Buy | 2,000 | $3.50 | $7,000.00 | +13.7% | 0.0% | -23.6% | |
| Sep 13, 2021 | Pepose Jay | Director | Buy | 12,631 | $4.75 | $59,997.25 | +597.8% | -17.7% | -47.4% | |
| Sep 2, 2021 | Benton Susan | Director | Buy | 20,000 | $4.57 | $91,400.00 | +503.0% | -20.1% | -51.2% | |
| Nov 19, 2020 | Meyer Alan R | Director | Buy | 1,771 | $0.00 | - | +0.4% | - | - | |
| Nov 19, 2020 | Sooch Mina | President And CEO | Buy | 11,524 | $0.00 | - | +1.5% | - | - | |
| Nov 19, 2020 | Gallagher Cam81 | Director | Buy | 8,865 | $0.00 | - | +61.2% | - | - | |
| Nov 19, 2020 | Rodgers Richard J | Director | Buy | 17,730 | $0.00 | - | +300.0% | - | - |